Clinical trials
Completed Retinal Vein Occlusion trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
163 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 7 |
| 2007 | 5 |
| 2008 | 3 |
| 2009 | 7 |
| 2010 | 10 |
| 2011 | 15 |
| 2012 | 16 |
| 2013 | 10 |
| 2014 | 10 |
| 2015 | 7 |
| 2016 | 11 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 8 |
| 2021 | 8 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 163 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 17 |
| Allergan | 16 |
| Bayer | 7 |
| National Eye Institute (NEI) | 6 |
| Barnes Retina Institute | 3 |
| California Retina Consultants | 3 |
| Genentech, Inc. | 3 |
| Medical University of Vienna | 3 |
| Peter A Campochiaro, MD | 3 |
| Regeneron Pharmaceuticals | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinal Vein Occlusion | 163 |
| Macular Edema | 84 |
| Macular Degeneration | 32 |
| Diabetic Retinopathy | 18 |
| Vision Disorders | 13 |
| Retinal Diseases | 8 |
| Choroidal Neovascularization | 6 |
| Wet Macular Degeneration | 6 |
| Eye Diseases | 5 |
| Geographic Atrophy | 5 |
Trials
Showing 76 to 100 of 163. Each trial links to its page on Pharma Observatory.
63 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.